Fig. 2.
Effects of hepsulfam on hematopoiesis. Hepsulfam (1.5 g/m2 intravenous bolus) produced thrombocytopenia (<100 × 109platelets/L) between day 12 and 25, with a nadir of 39 ± 20 × 109 platelets/L on day 17 (left). Neutropenia of less than 1 × 109 neutrophils/L occurred between day 8 and 30 following hepsulfam, with a nadir of 0.167 ± 0.120 × 109 neutrophils/L on day 15 (right).
